VivoSeq
Other

Frostbite

5

Pipeline Programs↗

4

Active Trials↗

1

Companies Involved↗

Frostbite is an early-stage landscape with 5 programs across 1 company. The most active players are AbbVie. 1 therapy is approved.

Intelligence

Pipeline Metrics

Competitive Density

31/100

Pipeline Velocity

11/100

Mech. Concentration

100/100

Completion Rate

0/100

Attrition Rate

20/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

AbbVie logo

AbbVie

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

5

clinical trials

Not yet recruiting2 · 40%
Recruiting1 · 20%
Active, not recruiting1 · 20%
Withdrawn1 · 20%

Clinical Trials

Trial Activity

Prevention and Treatment of Frostbite Infection With Antimicrobial Pharmacokinetic Analysis
Recruiting·UUniversity of Colorado, Denver·Phase 4·NCT06266494·100 enrolled
Epoprostenol Plus Conventional Therapy in COld and Frostbite Injury (ECCO)
Not yet recruiting·UUniversity of Colorado, Denver·Phase 4·NCT07424378·66 enrolled
Comparison of ICG Microangiography and Conventional Angiography in Severe Frostbite
Active, not recruiting·HHealthPartners Institute·N/A·NCT05777590·8 enrolled
Field Study on Intravenous Iloprost for Treatment of Severe Frostbite at High Altitude
Not yet recruiting·—·N/A·NCT07450469·10 enrolled
Treatment of Frostbite Sequelae With Botulinum Toxin A
Withdrawn·UUniversity Hospital of North Norway·Phase 2·NCT06460194

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)